Corona Remedies Ltd. Address
Listed
NSE & BSE
Mainboard
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
3,056,533
49.53% |
49.53%
|
₹324.60 |
|
NII / HNI
|
Over 1.00x
|
916,960
14.86% |
14.86%
|
₹97.38 |
|
Retail
|
Over 1.00x
|
2,139,573
34.67% |
34.67%
|
₹227.22 |
|
Employees
|
Awaited |
58,036
0.94% |
0.94%
|
₹6.16 |
| Total | 1.00x | 6,171,102 |
100% | ₹655.37 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 3,056,533 | ₹324.60 |
49.53%
|
| NII | 916,960 | ₹97.38 |
14.86%
|
| Retail | 2,139,573 | ₹227.22 |
34.67%
|
| Employee | 58,036 | ₹6.16 |
0.94%
|
| Total | 6,171,102 | ₹655.37 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 916,960 | 2,139,573 | 3,056,533 |
| Allotment price (₹) | 1,062 | 1,062 | 1,062 | 1,062 | 1,062 | 1,062 | 1,062 | 1,062 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹227.22 | ₹227.22 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 916,960 | 2,139,573 | 3,056,533 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 28 | ₹29,736 |
| Retail (Max — 13 Lots) | 13 | 182 | ₹193,284 |
| S-HNI (Min — 14 Lots) | 14 | 196 | ₹208,152 |
| B-HNI (Min — 68 Lots) | 68 | 952 | ₹1,011,024 |
Corona Remedies Ltd. Address is proposing an IPO on NSE & BSE under the Mainboard category. Total issue: 61,71,101 shares (aggregating up to ₹655.37 Cr).
Opens 08 Dec 2025, closes 10 Dec 2025. Listing: 15 Dec 2025. Apply via ASBA or UPI.
| Particulars | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 348.56 | 1202.35 | 1020.93 |
| EBITDA | 71.80 | 245.91 | 161.19 |
| Profit After Tax (PAT) | 46.20 | 149.43 | 90.50 |
| Net Worth | 607.02 | 606.34 | 480.41 |
| Total Assets | 1012.38 | 929.86 | 830.58 |
| Reserves & Surplus | 545.86 | 545.18 | 419.25 |
| Borrowings | 106.65 | 62.70 | 134.14 |
| EBITDA Margin (%) | 20.55% | — | — |
| PAT Margin (%) | 12.49% | — | — |
Corona Remedies Ltd. Address IPO is subscribed 1.00 times by Dec 10, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Corona Remedies Ltd. Address IPO retail category is subscribed 1.00 times as of 10 Dec 2025. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 08 Dec 2025 and closes 10 Dec 2025. Min investment: ₹14,868 (1 lot = 14 shares). UPI mandate: 2025-12-10.
The Corona Remedies Ltd. Address IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 16 Dec 2025. Refunds: on 17 Dec 2025.
The Corona Remedies Ltd. Address IPO listing date is 15 Dec 2025, Monday. Listed on: NSE & BSE. Issue price: ₹1,062. Estimated listing: ₹1,352. GMP: +₹290.
The Corona Remedies Ltd. Address IPO closes on 10 Dec 2025, Wednesday. UPI mandate: 2025-12-10. Allotment: 16 Dec 2025. Listing: 15 Dec 2025.